Loading insider details...
Latest Form 4 (Oct 7, 2026): Exercise/Conversion of 25,000 RXRX shares, $55.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Exercise/Conversion | 25,000 | $55.5K |
| Sep 11, 2026 | AtaiBeckley Inc. (ATAI) | Disposition to Issuer | 48,858 | n/a |
| Aug 20, 2026 | Adaptive Biotechnologies Corp (ADPT) | Exercise/Conversion | 15,000 | $94.8K |
| Jul 9, 2026 | AtaiBeckley Inc. (ATAI) | Exercise/Conversion | 48,858 | $66.0K |
| Jun 22, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/Award | 88,424 | n/a |
| Jun 9, 2026 | AtaiBeckley Inc. (ATAI) | Grant/Award | 121,968 | n/a |
| Mar 7, 2026 | Adaptive Biotechnologies Corp (ADPT) | Grant/Award | 15,625 | n/a |
| Dec 13, 2025 | Adaptive Biotechnologies Corp (ADPT) | Sale | 22,968 | $367.5K |
| Nov 6, 2025 | Atai Beckley N.V. (ATAI) | Grant/Award | 456,011 | n/a |
| Jun 23, 2025 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/Award | 22,016 | n/a |